检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).

Yosuke Kito,Hisato Kawakami,Seiichiro Mitani,Shinichi Nishina,Toshihiko Matsumoto,Takao Tsuzuki,Yudai Shinohara,Hozumi Shimokawa,Ryosuke Kumanishi,Takashi Ohta,Hiroo Katsuya,Takeshi Kawakami,Tomohiro Nishina,Hiroko Hasegawa,Kohei Akiyoshi,Yasutaka Chiba,Kentaro Yamazaki,Shuichi Hironaka,Kei Muro

The oncologist（2023）

引用 0|浏览16
暂无评分
摘要
Our data show the potential efficacy and acceptable safety profile of FTD/TPI plus bevacizumab for vulnerable patients with pretreated mCRC.
更多
查看译文
关键词
metastatic colorectal cancer, vulnerable patients, intensive therapy, trifluridine/tipiracil, bevacizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要